19/05/2025 – AB Science today announced that the Chinese Patent Office has issued a patent relating to methods of treating severe acute respiratory syndrome coronavirus 2 infection causing COVID-19 Download PDF Post navigationPreviousPrevious post:AB Science reports a new publication in the scientific journal PLOS OneRelated PostsAB Science reports a new publication in the scientific journal PLOS OneMay 15, 2025CNews – Interview of Alain MoussyMay 12, 2025Annual financial results as of 31 December, 2024May 12, 2025AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual MeetingMay 5, 2025AB Science will publish its 2024 annual financial report on May 9, 2025May 1, 2025European Medicines Agency has granted orphan drug designation in the European Union for AB8939 in the treatment of acute myeloid leukemiaApril 23, 2025
AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual MeetingMay 5, 2025
European Medicines Agency has granted orphan drug designation in the European Union for AB8939 in the treatment of acute myeloid leukemiaApril 23, 2025
